{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:00:49Z","timestamp":1790647249721,"version":"4.1.0"},"reference-count":21,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The aim of this retrospective study was to determine the difference in VEGF-A expression in adenocarcinoma and squamous cell cervical cancer and to show the influence of VEGF-A expression on clinical, pathological, and therapeutic prognostic factors on the outcome of treatment and the survival of patients. Materials and Methods: The study included patients with cervical cancer who were treated in the period from 1 January 2010 to 31 December 2021 at the Clinic for Gynecology and Obstetrics, University Hospital Centre, Osijek. The researchers conducted a retrospective analysis of data from patients\u2019 medical history, along with the pathohistological findings and oncologist findings. The study included 66 patients with cervical cancer (divided into two subgroups of 33 with adenocarcinoma or squamous cell cervical cancer). Diagnosis was based on the pathohistological status and FIGO staging. VEGF-A expression was significantly higher in adenocarcinoma. Subjects with a higher expression of VEGF-A had a significantly higher rate of disease progression and a higher possibility for lethal outcome. Results: Statistically significant prognostic factors in bivariate analysis in predicting a negative treatment outcome were: older age, greater depth of stromal invasion, FIGO IIB stage, chemotherapy, and positive lymph nodes. In the multivariate analysis, age and positive lymph nodes were shown to be significant predictors for a negative treatment outcome. Conclusions: VEGF-A has shown to be statistically more expressed in adenocarcinoma, which correlates with disease progression, but not statistically significant in multivariate regression analysis as an independent prognostic factor for poor survival of the subjects.<\/jats:p>","DOI":"10.3390\/medicina59071189","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T02:05:02Z","timestamp":1687745102000},"page":"1189","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Expression of Vascular Endothelial Growth Factor-A (VEGF-A) in Adenocarcinoma and Squamous Cell Cervical Cancer and Its Impact on Disease Progression: Single Institution Experience"],"prefix":"10.3390","volume":"59","author":[{"given":"Ivana","family":"Pi\u0161kur","sequence":"first","affiliation":[{"name":"Cathedra for Obstetrics and Gynecology, Faculty of Medicine, University of Osijek, Cara Hadrijana 10e, HR 31000 Osijek, Croatia"},{"name":"Clinic for Gynecology and Obstetrics, University Hospital Center Osijek, J. Huttlera 4, HR 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlatko","family":"Topolovec","sequence":"additional","affiliation":[{"name":"Cathedra for Obstetrics and Gynecology, Faculty of Medicine, University of Osijek, Cara Hadrijana 10e, HR 31000 Osijek, Croatia"},{"name":"Clinic for Gynecology and Obstetrics, University Hospital Center Osijek, J. Huttlera 4, HR 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bakula","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Hospital Center Osijek, J. Huttlera 4, HR 31000 Osijek, Croatia"},{"name":"Department of Pathology and Forensic Medicine, University Hospital Centre Osijek, J. Huttlera 4, HR 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Zagorac","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Hospital Center Osijek, J. Huttlera 4, HR 31000 Osijek, Croatia"},{"name":"Department of Pathology and Forensic Medicine, University Hospital Centre Osijek, J. Huttlera 4, HR 31000 Osijek, Croatia"},{"name":"Faculty of Dental Medicine and Health, University of Osijek, Crkvena ulica 21, HR 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8223-0974","authenticated-orcid":false,"given":"Iva","family":"Mili\u0107 Vranje\u0161","sequence":"additional","affiliation":[{"name":"Cathedra for Obstetrics and Gynecology, Faculty of Medicine, University of Osijek, Cara Hadrijana 10e, HR 31000 Osijek, Croatia"},{"name":"Clinic for Gynecology and Obstetrics, University Hospital Center Osijek, J. Huttlera 4, HR 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0621-5403","authenticated-orcid":false,"given":"Domagoj","family":"Vidosavljevi\u0107","sequence":"additional","affiliation":[{"name":"Cathedra for Obstetrics and Gynecology, Faculty of Medicine, University of Osijek, Cara Hadrijana 10e, HR 31000 Osijek, Croatia"},{"name":"Department of Obstetrics and Gynecology, National Memorial Hospital, Bolni\u010dka 5, HR 32000 Vukovar, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"key":"ref_1","unstructured":"Croatian Institute for Public Health (2023, January 10). Epidemiology of Cervical Cancer. (In Croatian). Available online: https:\/\/www.hzjz.hr\/aktualnosti\/epidemiologija-raka-vrata-maternice\/."},{"key":"ref_2","unstructured":"Croatian Institute for Public Health (2022, December 20). National Cancer Registry for 2018. Available online: https:\/\/www.hzjz.hr\/wpcontent\/uploads\/2020\/12\/Bilten_2018_final.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"ref_4","unstructured":"Kurman, R.J. (2002). Blaustein\u2019s Pathology of the Female Genital Tract, Springer. [5th ed.]."},{"key":"ref_5","unstructured":"Fox, H. (2003). Haines and Taylor Obstetrical and Gynaecological Pathology, Churchill Livingstone. [5th ed.]. Chapter 8\u201310."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Vinh-Hung, V., Bourgain, C., Vlastos, G., Cserni, G., De Ridder, M., Storme, G., and Vlastos, A.T. (2007). Prognostic value of histopathology and trends in cervical cancer: A SEER population study. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-164"},{"key":"ref_7","unstructured":"Stanec, M., Vrdoljak, D.M., and Turi\u0107, M. (2011). Surgical Oncology, Medicinska Naklada."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"24797","DOI":"10.18632\/oncotarget.15044","article-title":"Prognostic role of vascular endothelial growth factor in cervical cancer: A meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1080\/01443615.2021.1963691","article-title":"Association between single nucleotide polymorphisms of VEGF gene and pelvic lymph node metastasis in patients with early-stage cervical cancer","volume":"42","author":"Zhong","year":"2022","journal-title":"J. Obs. Gynaecol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Guo, H., Li, J., Fan, F., and Zhou, P. (2021). LINC00707 Regulates miR-382-5p\/VEGFA Pathway to Enhance Cervical Cancer Progression. J. Immunol. Res., 2021.","DOI":"10.1155\/2021\/5524632"},{"key":"ref_11","first-page":"1129","article-title":"Levels of vascular endothelial growth factor in serum and pleural fluid are independent predictors of survival in advanced non-small cell lung cancer: Results of a prospective study","volume":"35","author":"Gkiozos","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00384-012-1570-z","article-title":"Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection","volume":"28","author":"Tsai","year":"2013","journal-title":"Int. J. Color. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Cheng, D., Liang, B., and Li, Y. (2013). Serum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055309"},{"key":"ref_14","first-page":"447","article-title":"Vascular endothelial growth factor and intratumoral microvessel density as prognostic factors in endometrial cancer","volume":"34","author":"Topolovec","year":"2010","journal-title":"Coll. Antropol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12672-022-00551-9","article-title":"Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: A review","volume":"13","author":"Arip","year":"2022","journal-title":"Discov. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12958-022-00995-2","article-title":"linc00958\/miR-185-5p\/RSF-1 modulates cisplatin resistance and angiogenesis through AKT1\/GSK3\u03b2\/VEGFA pathway in cervical cancer","volume":"20","author":"Tian","year":"2022","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sidorkiewicz, I., Zbucka-Kr\u0119towska, M., Zar\u0119ba, K., Lubowicka, E., Zajkowska, M., Szmitkowski, M., Gacuta, E., and \u0141awicki, S. (2019). Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5558-8"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3889\/oamjms.2018.089","article-title":"Prognostic Significance of Vascular Endothelial Growth Factor (VEGF) and Her-2 Protein in the Genesis of Cervical Carcinoma","volume":"6","author":"Rahmani","year":"2018","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ygyno.2010.11.022","article-title":"A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA","volume":"120","author":"Lee","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"26057","DOI":"10.18632\/oncotarget.15220","article-title":"Incorporation of the number of positive lymph nodes leads to better prognostic discrimination of node-positive early stage cervical cancer","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"ref_21","first-page":"A226","article-title":"Adenocarcinoma versus squamous cell carcinoma of cervix: Are we fighting two different beasts with same weapon","volume":"29","author":"Islam","year":"2019","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/7\/1189\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:59:31Z","timestamp":1760126371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/7\/1189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["medicina59071189"],"URL":"https:\/\/doi.org\/10.3390\/medicina59071189","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,23]]}}}